Alzheimer’s Drug Semaglutide Fails to Show Efficacy
In recent developments, the Alzheimer’s drug semaglutide has generated significant interest among researchers and healthcare professionals, as it was initially thought to have potential benefits for dementia treatment.Semaglutide, also known for its use in the Wegovy medication, is a GLP-1 receptor agonist commonly prescribed for weight loss and managing type 2 diabetes.










